These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3004 related articles for article (PubMed ID: 32221519)

  • 1. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
    Zhao J; Yuan Q; Wang H; Liu W; Liao X; Su Y; Wang X; Yuan J; Li T; Li J; Qian S; Hong C; Wang F; Liu Y; Wang Z; He Q; Li Z; He B; Zhang T; Fu Y; Ge S; Liu L; Zhang J; Xia N; Zhang Z
    Clin Infect Dis; 2020 Nov; 71(16):2027-2034. PubMed ID: 32221519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
    Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
    Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
    PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
    Orner EP; Rodgers MA; Hock K; Tang MS; Taylor R; Gardiner M; Olivo A; Fox A; Prostko J; Cloherty G; Farnsworth CW
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115300. PubMed ID: 33388575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
    Kong WH; Zhao R; Zhou JB; Wang F; Kong DG; Sun JB; Ruan QF; Liu MQ
    Virol Sin; 2020 Dec; 35(6):752-757. PubMed ID: 32705575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.
    Lou B; Li TD; Zheng SF; Su YY; Li ZY; Liu W; Yu F; Ge SX; Zou QD; Yuan Q; Lin S; Hong CM; Yao XY; Zhang XJ; Wu DH; Zhou GL; Hou WH; Li TT; Zhang YL; Zhang SY; Fan J; Zhang J; Xia NS; Chen Y
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32430429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Multiplex Analysis of SARS-CoV-2 Specific Antibodies in COVID-19 Disease.
    Brynjolfsson SF; Sigurgrimsdottir H; Einarsdottir ED; Bjornsdottir GA; Armannsdottir B; Baldvinsdottir GE; Bjarnason A; Gudlaugsson O; Gudmundsson S; Sigurdardottir ST; Love A; Kristinsson KG; Ludviksson BR
    Front Immunol; 2021; 12():695230. PubMed ID: 34177962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
    Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y
    PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
    Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
    Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay.
    Higgins RL; Rawlings SA; Case J; Lee FY; Chan CW; Barrick B; Burger ZC; Yeo KJ; Marrinucci D
    PLoS One; 2021; 16(3):e0247797. PubMed ID: 33661960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.
    Qin X; Shen J; Dai E; Li H; Tang G; Zhang L; Hou X; Lu M; Wu X; Duan S; Zhang J; Tsoi MF; Jiang P; Li Y
    BMC Immunol; 2021 Feb; 22(1):14. PubMed ID: 33596826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 151.